Zdrowie i gospodarka · 10/10/2018
FDA Releases Draft Guidance on Assessing Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems
The FDA has released a draft guidance for industry on evaluating the skin irritation and sensitization potential of transdermal and topical delivery systems for abbreviated new drug applications.